Max Healthcare Institute Ltd
NSE:MAXHEALTH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
964.3
1 299.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd., a prominent player in the Indian healthcare landscape, has woven its narrative by consistently providing top-tier healthcare services across the country. Founded as a partnership between Max India Limited and the renowned healthcare provider, Life Healthcare of South Africa, Max Healthcare has expanded its reach with a network of multispecialty hospitals, catering to various medical needs. The company prides itself on delivering holistic and patient-centric care, offering a wide array of services ranging from complex surgeries and emergency care to preventive health services and diagnostics. This comprehensive approach ensures that Max Healthcare not only addresses immediate health needs but also emphasizes long-term wellness, thus fortifying its reputation as a reliable healthcare provider.
Financially, Max Healthcare Institute thrives on its diversified revenue streams. These streams are primarily built on inpatient and outpatient services, where it capitalizes on its state-of-the-art infrastructure and advanced medical technology to attract patients. Additionally, Max Healthcare leverages its brand to engage in partnerships, collaborations, and clinical research, thereby generating ancillary revenue. The company also benefits from health awareness programs and corporate health tie-ups, which feed a steady flow of patients into its facilities. Through these strategic efforts, Max Healthcare has established a robust framework that supports its profitability while continuing to expand its footprint in the increasingly competitive healthcare industry in India.
Max Healthcare Institute Ltd., a prominent player in the Indian healthcare landscape, has woven its narrative by consistently providing top-tier healthcare services across the country. Founded as a partnership between Max India Limited and the renowned healthcare provider, Life Healthcare of South Africa, Max Healthcare has expanded its reach with a network of multispecialty hospitals, catering to various medical needs. The company prides itself on delivering holistic and patient-centric care, offering a wide array of services ranging from complex surgeries and emergency care to preventive health services and diagnostics. This comprehensive approach ensures that Max Healthcare not only addresses immediate health needs but also emphasizes long-term wellness, thus fortifying its reputation as a reliable healthcare provider.
Financially, Max Healthcare Institute thrives on its diversified revenue streams. These streams are primarily built on inpatient and outpatient services, where it capitalizes on its state-of-the-art infrastructure and advanced medical technology to attract patients. Additionally, Max Healthcare leverages its brand to engage in partnerships, collaborations, and clinical research, thereby generating ancillary revenue. The company also benefits from health awareness programs and corporate health tie-ups, which feed a steady flow of patients into its facilities. Through these strategic efforts, Max Healthcare has established a robust framework that supports its profitability while continuing to expand its footprint in the increasingly competitive healthcare industry in India.
Strong Growth: Max Healthcare delivered 21% year-on-year revenue growth and 23% EBITDA growth for Q2 FY26, marking 20 consecutive quarters of consistent growth.
Margin Expansion: Network operating EBITDA margin reached 26.9%, up by 90 basis points YoY and 200 bps sequentially; existing units saw margins of 27.5%.
Profit Boosted by One-Time Gain: PAT surged to INR 554 crores (including a one-time tax benefit of INR 149 crores from a merger); underlying PAT growth was 16% YoY.
Capacity Expansion: Several brownfield projects were commissioned or are close to commissioning, adding significant new bed capacity to the network.
CGHS Tariff Increase: Full implementation of revised government healthcare rates is expected to add over INR 200 crores in additional revenue, with most benefits realized from FY27.
International Patient Growth: International patient revenue grew by 25% YoY, driven almost entirely by volume increases; international ARPOB is about 30% higher than domestic.
Resolution of Insurance Issues: Disputes with key insurance companies were resolved, and cashless facilities are reinstated; future insurance negotiations are ongoing but expected to follow historical trends.
Digital & Asset-Light Segments: Digital revenue accounted for 30% of total, and asset-light businesses like Max@Home and Max Lab posted strong double-digit revenue growth.